Chronic atrophic gastritis
Conditions
Interventions
Umbilical Ring Point Treatment Group:Acupuncture at the umbilicus ring acupoint and administration of Lansoprazole enteric-coated capsules orally.
Longji Moxibustion Treatment Group:Dragon spine moxibustion and oral administration of lansoprazole enteric-coated capsules.
Combined Treatment Group of Umbilical Ring Point and Dragon Spine Moxibustion:Acupuncture at the Zhuang medical umbilical ring acupoint combined with dragon spine moxibustion and oral administration o
Western medicine control group:Lansoprazole enteric-coated capsules orally.
Sponsors
Youjiang Medical University for Nationalities
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Those who meet the diagnostic criteria for chronic atrophic gastritis in Western medicine; 2. Patients with Yang deficiency constitution and epigastric pain in Traditional Chinese Medicine; 3. Patients with "Dong Yin" (epigastric pain) in Zhuang medicine; 4. Patients aged between 20 and 60 years, with no restriction on gender; 5. Patients without severe diseases in other systems; 6. All participants have given informed consent and voluntarily joined this trial, and are able to actively cooperate with the treatment under the careful guidance of physicians.
Exclusion criteria
Exclusion criteria: 1.Those who do not meet the inclusion criteria; 2. Patients under 20 years old or over 60 years old; 3.Patients with severe complications, such as cardio-cerebrovascular diseases, severe liver and kidney dysfunction, massive gastrointestinal bleeding, or malignant tumors; 4.Patients with severe mental disorders; 5.Patients in the lactation period; 6.Patients who do not actively cooperate to complete the prescribed course of treatment..
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastric mucosa pathohistological improvement rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The therapeutic effects of clinical symptoms in Western medicine;Traditional Chinese Medicine (TCM) Syndrome Efficacy;Efficacy of gastroscopy;High-throughput transcriptome sequencing of exosomes in blood and gastric mucosa;Serum and gastric mucosa TRPV1, calcitonin gene-related peptide (CGRP), and substance P (SP); | — |
Countries
China
Contacts
Public ContactHuina Ma
Youjiang Medical University for Nationalities
Outcome results
None listed